Ownership history in Commodore Capital LP · 21 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in XENON PHARMACEUTICALS INC (XENE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,800,000 | -900,000 | -33.3% | 5.37% | $80.7M | $44.82 |
| 2025 Q3 | REDUCED | 2,700,000 | -325,000 | -10.7% | 5.29% | $108.4M | $40.15 |
| 2025 Q2 | ADDED | 3,025,000 | +700,000 | +30.1% | 6.68% | $94.7M | $31.30 |
| 2025 Q1 | REDUCED | 2,325,000 | -415,000 | -15.1% | 5.75% | $78.0M | $33.55 |
As of 2025 Q4 — sorted by position size